Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 11, 2026

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

CD23 expression in plasma cell leukaemia

Gabriele Buda, Giovanni Carulli, Enrico Orciuolo

    British Journal of Haematology
    |July 16, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
    06:38

    Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

    Published on: November 8, 2011

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
    09:01

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

    Published on: March 26, 2018

    Related Experiment Videos

    Last Updated: Jun 11, 2026

    In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
    10:26

    In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

    Published on: January 20, 2019

    Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
    06:38

    Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

    Published on: November 8, 2011

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
    09:01

    Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

    Published on: March 26, 2018

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    MRD in multiple myeloma: Moving from "minimal" to "measurable".

    Blood reviews·2026
    Same author

    Early Soluble B-Cell Maturation Antigen (BCMA/TNFRSF17) Kinetics as a Molecular Biomarker of Treatment Response in Multiple Myeloma Patients.

    International journal of molecular sciences·2026
    Same author

    Real-world patient-reported symptomatic adverse events and concordance with physician assessments after CAR T-cell therapy in patients with aggressive B-cell lymphomas: a prospective study.

    The Lancet. Haematology·2026
    Same author

    Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy.

    The New England journal of medicine·2026
    Same author

    MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM.

    British journal of haematology·2026
    Same author

    A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasone.

    Haematologica·2026